Correlation Between Zaptec AS and Stayble Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zaptec AS and Stayble Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zaptec AS and Stayble Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zaptec AS and Stayble Therapeutics AB, you can compare the effects of market volatilities on Zaptec AS and Stayble Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zaptec AS with a short position of Stayble Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zaptec AS and Stayble Therapeutics.

Diversification Opportunities for Zaptec AS and Stayble Therapeutics

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Zaptec and Stayble is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Zaptec AS and Stayble Therapeutics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stayble Therapeutics and Zaptec AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zaptec AS are associated (or correlated) with Stayble Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stayble Therapeutics has no effect on the direction of Zaptec AS i.e., Zaptec AS and Stayble Therapeutics go up and down completely randomly.

Pair Corralation between Zaptec AS and Stayble Therapeutics

Assuming the 90 days trading horizon Zaptec AS is expected to under-perform the Stayble Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Zaptec AS is 1.92 times less risky than Stayble Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Stayble Therapeutics AB is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  32.00  in Stayble Therapeutics AB on September 14, 2024 and sell it today you would earn a total of  15.00  from holding Stayble Therapeutics AB or generate 46.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.6%
ValuesDaily Returns

Zaptec AS  vs.  Stayble Therapeutics AB

 Performance 
       Timeline  
Zaptec AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zaptec AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Stayble Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Stayble Therapeutics AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Zaptec AS and Stayble Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zaptec AS and Stayble Therapeutics

The main advantage of trading using opposite Zaptec AS and Stayble Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zaptec AS position performs unexpectedly, Stayble Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stayble Therapeutics will offset losses from the drop in Stayble Therapeutics' long position.
The idea behind Zaptec AS and Stayble Therapeutics AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
CEOs Directory
Screen CEOs from public companies around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.